Yanmei Hu - Search Results

Year	Number of Results
2013	1
2014	2
2015	2
2016	6
2017	11
2018	7
2019	12
2020	18
2021	18
2022	14
2023	8
2024	4

1

Enterovirus D68 Antivirals: Past, Present, and Future.

Hu Y, Musharrafieh R, Zheng M, Wang J. Hu Y, et al. ACS Infect Dis. 2020 Jul 10;6(7):1572-1586. doi: 10.1021/acsinfecdis.0c00120. Epub 2020 May 14. ACS Infect Dis. 2020. PMID: 32352280 Free PMC article. Review.

2

AI is a viable alternative to high throughput screening: a 318-target study.

Atomwise AIMS Program. Atomwise AIMS Program. Sci Rep. 2024 Apr 2;14(1):7526. doi: 10.1038/s41598-024-54655-z. Sci Rep. 2024. PMID: 38565852 Free PMC article.

3

Progress and Challenges in Targeting the SARS-CoV-2 Papain-like Protease.

Tan H, Hu Y, Jadhav P, Tan B, Wang J. Tan H, et al. Among authors: hu y. J Med Chem. 2022 Jun 9;65(11):7561-7580. doi: 10.1021/acs.jmedchem.2c00303. Epub 2022 May 27. J Med Chem. 2022. PMID: 35620927 Free PMC article. Review.

4

Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir.

Hu Y, Lewandowski EM, Tan H, Zhang X, Morgan RT, Zhang X, Jacobs LMC, Butler SG, Gongora MV, Choy J, Deng X, Chen Y, Wang J. Hu Y, et al. ACS Cent Sci. 2023 Jul 24;9(8):1658-1669. doi: 10.1021/acscentsci.3c00538. eCollection 2023 Aug 23. ACS Cent Sci. 2023. PMID: 37637734 Free PMC article.

5

SARS-CoV-2 Main Protease Drug Design, Assay Development, and Drug Resistance Studies.

Tan B, Joyce R, Tan H, Hu Y, Wang J. Tan B, et al. Among authors: hu y. Acc Chem Res. 2023 Jan 17;56(2):157-168. doi: 10.1021/acs.accounts.2c00735. Epub 2022 Dec 29. Acc Chem Res. 2023. PMID: 36580641 Free PMC article.

6

Telaprevir Treatment Reduces Paralysis in a Mouse Model of Enterovirus D68 Acute Flaccid Myelitis.

Frost J, Rudy MJ, Leser JS, Tan H, Hu Y, Wang J, Clarke P, Tyler KL. Frost J, et al. Among authors: hu y. J Virol. 2023 May 31;97(5):e0015623. doi: 10.1128/jvi.00156-23. Epub 2023 May 8. J Virol. 2023. PMID: 37154751 Free PMC article.

7

Enterovirus A71 antivirals: Past, present, and future.

Wang J, Hu Y, Zheng M. Wang J, et al. Among authors: hu y. Acta Pharm Sin B. 2022 Apr;12(4):1542-1566. doi: 10.1016/j.apsb.2021.08.017. Epub 2021 Aug 20. Acta Pharm Sin B. 2022. PMID: 35847514 Free PMC article.

8

Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development.

Zhang J, Hu Y, Musharrafieh R, Yin H, Wang J. Zhang J, et al. Among authors: hu y. Curr Med Chem. 2019;26(13):2243-2263. doi: 10.2174/0929867325666180706112940. Curr Med Chem. 2019. PMID: 29984646 Free PMC article. Review.

9

Systematic Review of Adverse Effects: A Further Step towards Modernization of Acupuncture in China.

Wu J, Hu Y, Zhu Y, Yin P, Litscher G, Xu S. Wu J, et al. Among authors: hu y. Evid Based Complement Alternat Med. 2015;2015:432467. doi: 10.1155/2015/432467. Epub 2015 Aug 3. Evid Based Complement Alternat Med. 2015. PMID: 26339265 Free PMC article. Review.

10

Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target.

Hu Y, Sneyd H, Dekant R, Wang J. Hu Y, et al. Curr Top Med Chem. 2017;17(20):2271-2285. doi: 10.2174/1568026617666170224122508. Curr Top Med Chem. 2017. PMID: 28240183 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

94 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year